Comparison of Tc-99m maraciclatide and Tc-99m sestamibi molecular breast imaging in patients with suspected breast cancer
Sign Up to like & getrecommendations! Published in 2017 at "EJNMMI Research"
DOI: 10.1186/s13550-017-0255-6
Abstract: BackgroundMolecular breast imaging (MBI) performed with 99mTc sestamibi has been shown to be a valuable technique for the detection of breast cancer. Alternative radiotracers such as 99mTc maraciclatide may offer improved uptake in breast lesions.… read more here.
Keywords: 99mtc maraciclatide; 99mtc sestamibi; breast cancer;